Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Other Non Operating Income: 2010-2024

Historic Other Non Operating Income for Altimmune (ALT) over the last 15 years, with Dec 2024 value amounting to $48,000.

  • Altimmune's Other Non Operating Income fell 577.78% to -$86,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$45,000, marking a year-over-year increase of 10.00%. This contributed to the annual value of $48,000 for FY2024, which is 71.08% down from last year.
  • According to the latest figures from FY2024, Altimmune's Other Non Operating Income is $48,000, which was down 71.08% from $166,000 recorded in FY2023.
  • Altimmune's Other Non Operating Income's 5-year high stood at $166,000 during FY2023, with a 5-year trough of -$374,000 in FY2021.
  • In the last 3 years, Altimmune's Other Non Operating Income had a median value of $48,000 in 2024 and averaged $60,667.
  • As far as peak fluctuations go, Altimmune's Other Non Operating Income crashed by 1,648.85% in 2021, and later surged by 618.75% in 2023.
  • Yearly analysis of 5 years shows Altimmune's Other Non Operating Income stood at $24,147 in 2020, then plummeted by 1,648.85% to -$374,000 in 2021, then skyrocketed by 91.44% to -$32,000 in 2022, then surged by 618.75% to $166,000 in 2023, then plummeted by 71.08% to $48,000 in 2024.